Literature DB >> 24646737

Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection.

Cortney E Heim1, Debbie Vidlak, Tyler D Scherr, Jessica A Kozel, Melissa Holzapfel, David E Muirhead, Tammy Kielian.   

Abstract

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature monocytes and granulocytes that are potent inhibitors of T cell activation. A role for MDSCs in bacterial infections has only recently emerged, and nothing is known about MDSC function in the context of Staphylococcus aureus infection. Because S. aureus biofilms are capable of subverting immune-mediated clearance, we examined whether MDSCs could play a role in this process. CD11b(+)Gr-1(+) MDSCs represented the main cellular infiltrate during S. aureus orthopedic biofilm infection, accounting for >75% of the CD45+ population. Biofilm-associated MDSCs inhibited T cell proliferation and cytokine production, which correlated with a paucity of T cell infiltrates at the infection site. Analysis of FACS-purified MDSCs recovered from S. aureus biofilms revealed increased arginase-1, inducible NO synthase, and IL-10 expression, key mediators of MDSC suppressive activity. Targeted depletion of MDSCs and neutrophils using the mAb 1A8 (anti-Ly6G) improved bacterial clearance by enhancing the intrinsic proinflammatory attributes of infiltrating monocytes and macrophages. Furthermore, the ability of monocytes/macrophages to promote biofilm clearance in the absence of MDSC action was revealed with RB6-C85 (anti-Gr-1 or anti-Ly6G/Ly6C) administration, which resulted in significantly increased S. aureus burdens both locally and in the periphery, because effector Ly 6C monocytes and, by extension, mature macrophages were also depleted. Collectively, these results demonstrate that MDSCs are key contributors to the chronicity of S. aureus biofilm infection, as their immunosuppressive function prevents monocyte/macrophage proinflammatory activity, which facilitates biofilm persistence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24646737      PMCID: PMC4004612          DOI: 10.4049/jimmunol.1303408

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  72 in total

Review 1.  Current concepts in osteolysis.

Authors:  B Ollivere; J A Wimhurst; I M Clark; S T Donell
Journal:  J Bone Joint Surg Br       Date:  2012-01

2.  The terminology issue for myeloid-derived suppressor cells.

Authors:  Dmitry I Gabrilovich; Vincenzo Bronte; Shu-Hsia Chen; Mario P Colombo; Augusto Ochoa; Suzanne Ostrand-Rosenberg; Hans Schreiber
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

3.  Murine immune response to a chronic Staphylococcus aureus biofilm infection.

Authors:  Ranjani Prabhakara; Janette M Harro; Jeff G Leid; Megan Harris; Mark E Shirtliff
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

4.  Ly6C+ Ly6G- Myeloid-derived suppressor cells play a critical role in the resolution of acute inflammation and the subsequent tissue repair process after spinal cord injury.

Authors:  Hirokazu Saiwai; Hiromi Kumamaru; Yasuyuki Ohkawa; Kensuke Kubota; Kazu Kobayakawa; Hisakata Yamada; Takehiko Yokomizo; Yukihide Iwamoto; Seiji Okada
Journal:  J Neurochem       Date:  2013-01-15       Impact factor: 5.372

5.  Staphylococcus epidermidis biofilms with higher proportions of dormant bacteria induce a lower activation of murine macrophages.

Authors:  Filipe Cerca; Filipa Andrade; Ângela França; Elva Bonifácio Andrade; Adília Ribeiro; Agostinho A Almeida; Nuno Cerca; Gerald Pier; Joana Azeredo; Manuel Vilanova
Journal:  J Med Microbiol       Date:  2011-07-28       Impact factor: 2.472

6.  Induction of myeloid-derived suppressor cells by tumor exosomes.

Authors:  Xiaoyu Xiang; Anton Poliakov; Cunren Liu; Yuelong Liu; Zhong-bin Deng; Jianhua Wang; Ziqiang Cheng; Spandan V Shah; Gui-Jun Wang; Liming Zhang; William E Grizzle; Jim Mobley; Huang-Ge Zhang
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

7.  Global transcriptome analysis of Staphylococcus aureus biofilms in response to innate immune cells.

Authors:  Tyler D Scherr; Christelle M Roux; Mark L Hanke; Amanda Angle; Paul M Dunman; Tammy Kielian
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

8.  A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings.

Authors:  Nicholas M Bernthal; Alexandra I Stavrakis; Fabrizio Billi; John S Cho; Thomas J Kremen; Scott I Simon; Ambrose L Cheung; Gerald A Finerman; Jay R Lieberman; John S Adams; Lloyd S Miller
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

9.  A secreted bacterial protease tailors the Staphylococcus aureus virulence repertoire to modulate bone remodeling during osteomyelitis.

Authors:  James E Cassat; Neal D Hammer; J Preston Campbell; Meredith A Benson; Daniel S Perrien; Lara N Mrak; Mark S Smeltzer; Victor J Torres; Eric P Skaar
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

Review 10.  Community-associated methicillin-resistant Staphylococcus aureus immune evasion and virulence.

Authors:  Shawna F Graves; Scott D Kobayashi; Frank R DeLeo
Journal:  J Mol Med (Berl)       Date:  2010-01-05       Impact factor: 4.599

View more
  82 in total

Review 1.  Ventricular shunt infections: immunopathogenesis and clinical management.

Authors:  Yenis Gutierrez-Murgas; Jessica N Snowden
Journal:  J Neuroimmunol       Date:  2014-08-13       Impact factor: 3.478

2.  Interleukin-10 Produced by Myeloid-Derived Suppressor Cells Provides Protection to Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 258 by Enhancing Its Clearance in the Airways.

Authors:  Hernán F Peñaloza; Loreani P Noguera; Danielle Ahn; Omar P Vallejos; Raquel M Castellanos; Yaneisi Vazquez; Francisco J Salazar-Echegarai; Liliana González; Isidora Suazo; Catalina Pardo-Roa; Geraldyne A Salazar; Alice Prince; Susan M Bueno
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

3.  Murine myeloid-derived suppressor cells are a source of elevated levels of interleukin-27 in early life and compromise control of bacterial infection.

Authors:  Madeline Gleave Parson; Juanita Grimmett; Jordan K Vance; Michelle R Witt; Brittany G Seman; Travis W Rawson; Logan Lyda; Christopher Labuda; Joo-Yong Jung; Shelby D Bradford; Cory M Robinson
Journal:  Immunol Cell Biol       Date:  2019-02-08       Impact factor: 5.126

Review 4.  Biofilms 2018: A diversity of microbes and mechanisms.

Authors:  Clay Fuqua; Alain Filloux; Jean-Marc Ghigo; Karen L Visick
Journal:  J Bacteriol       Date:  2019-02-19       Impact factor: 3.490

Review 5.  Low-Virulence Organisms and Periprosthetic Joint Infection-Biofilm Considerations of These Organisms.

Authors:  K Keely Boyle; Stuart Wood; T David Tarity
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

Review 6.  Staphylococcal Biofilms.

Authors:  Michael Otto
Journal:  Microbiol Spectr       Date:  2018-08

7.  SaeRS Is Responsive to Cellular Respiratory Status and Regulates Fermentative Biofilm Formation in Staphylococcus aureus.

Authors:  Ameya A Mashruwala; Casey M Gries; Tyler D Scherr; Tammy Kielian; Jeffrey M Boyd
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

8.  Cyclic di-AMP Released from Staphylococcus aureus Biofilm Induces a Macrophage Type I Interferon Response.

Authors:  Casey M Gries; Eric L Bruger; Derek E Moormeier; Tyler D Scherr; Christopher M Waters; Tammy Kielian
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

Review 9.  Staphylococcal Biofilms and Immune Polarization During Prosthetic Joint Infection.

Authors:  Casey M Gries; Tammy Kielian
Journal:  J Am Acad Orthop Surg       Date:  2017-02       Impact factor: 3.020

10.  IL-12 promotes myeloid-derived suppressor cell recruitment and bacterial persistence during Staphylococcus aureus orthopedic implant infection.

Authors:  Cortney E Heim; Debbie Vidlak; Tyler D Scherr; Curtis W Hartman; Kevin L Garvin; Tammy Kielian
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.